Please login to the form below

Not currently logged in
Email:
Password:

RPSGB promotes excellence In pharmacy research

The Royal Pharmaceutical Society of Great Britain (RPSGB) has awarded the University of Nottingham's School of Pharmacy with a platform to promote the next generation of research talent.

The Royal Pharmaceutical Society of Great Britain (RPSGB) has awarded the University of Nottingham's School of Pharmacy with a platform to promote the next generation of research talent.

The School of Pharmacy will host an Academic Excellence Award in 2008, which is a prestigious programme of PhD studentships offered by the RPSGB.

Nottingham was one of only two UK institutions selected from among 23 applicants, after a judging process involving a panel of distinguished pharmacy academics.

The RPSGB Academic Excellence Awards hope to increase the number of pharmacists who enter and stay in academia as a career by providing funding to enable exceptional pharmacists and pharmacy graduates to undertake PhD training. The scheme promotes the important role played by members of the academic workforce in developing and leading the profession of pharmacy.

The University will host an award for research with the title 'Selective inhibitors for nuclear receptors: an alternative to anti-hormone therapies', supervised by Professor David Heery. This work investigates the mechanisms by which genes are switched on or off in healthy or diseased human cells.

The award is only the latest accolade for the highly-rated School of Pharmacy. In April this year the School won a Queen's Award for Enterprise in the category of Innovation. Cardiff University was the other institution to be successful in the Academic Excellence Awards for 2008.

20th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics